Abdominal Aortic Aneurysm: Screening and Surveillance

Definition and Pathophysiology

An abdominal aortic aneurysm (AAA) is diagnosed when the abdominal aortic diameter exceeds 3 cm. Most AAAs are located below the renal arteries and are related to atherosclerotic disease. At least 90% of AAAs larger than 4 cm are associated with atherosclerotic pathology.

AAA prevalence increases with age and is approximately five times higher in males than females, although the sex difference becomes less pronounced in older age. Cigarette smoking is a major modifiable risk factor. Family history also increases risk, particularly among first-degree relatives, with siblings appearing to be especially affected.

The principal determinant of adverse outcome is aneurysm size. Larger aneurysms and more rapid expansion are associated with increasing likelihood of symptoms, complications and rupture. Aneurysmal sacs may contain mural thrombus, which can contribute to peripheral embolization and may reduce the apparent luminal diameter on contrast aortography.

AAA growth is variable. Aneurysms smaller than 4 cm may enlarge by approximately 1.5–2 mm per year, whereas larger aneurysms generally expand more rapidly. Rapid enlargement is defined in the source recommendations as at least 10 mm per year or at least 5 mm over 6 months. Such growth may justify consideration of repair at a smaller diameter than would otherwise be used.

Women have growth rates similar to men but a substantially higher rupture risk; one guideline summary describes approximately a four-fold greater risk. This difference informs the use of sex-specific surveillance and repair thresholds.

Clinical Presentation and Symptoms

Most AAAs are asymptomatic and are identified either during routine abdominal examination or incidentally on imaging performed for another indication.

When palpable, an AAA may present as a pulsatile, expansile and generally nontender abdominal mass. Some patients report prominent abdominal pulsations. Expansion may produce pain in the abdomen, chest, lower back or scrotum. Aneurysmal pain is clinically important because it may herald rupture and constitutes a medical emergency.

Rupture may occur without preceding symptoms. Typical acute manifestations include severe pain, hypotension and abdominal tenderness. Leakage or rupture is life-threatening and requires emergency operation or endovascular repair.

AAA may also be associated with mesenteric ischemia or acute renal failure, either through atherosclerotic or atherothrombotic disease. Mural thrombus may predispose to peripheral embolization.

Evaluation and Physical Examination

The abdominal aorta may be palpable in the mid-abdominal region, with its bifurcation usually located near the umbilicus and the fourth lumbar vertebral level. Physical examination can identify a large aneurysm as a palpable, pulsatile, expansile mass, although absence of a palpable abnormality does not exclude AAA.

Plain abdominal radiography has limited sensitivity. A calcified aneurysmal outline may be visible, but approximately one quarter of aneurysms are not calcified and therefore cannot be identified reliably by radiography.

Assessment should include consideration of associated vascular disease. In patients with AAA, duplex ultrasound screening for femoropopliteal aneurysms should be considered. Opportunistic screening may also be useful in patients with symptomatic or asymptomatic peripheral arterial disease, in whom AAA has been reported with a substantial cumulative incidence.

The source material does not provide a detailed standardized physical-examination protocol beyond assessment for a pulsatile abdominal mass and associated manifestations.

Screening for AAA

General principles

Duplex ultrasound is the preferred screening modality because it is noninvasive, avoids ionizing radiation and contrast agents, and accurately identifies abdominal aortic enlargement. Screening reduces aneurysm-related mortality in populations with a high prevalence of AAA, particularly older male smokers.

The evidence for benefit in women is less certain, although screening may be reasonable in older women who have smoked. Screening by noncontrast CT has not demonstrated effectiveness over 5 years in the cited male population, and no recommendation is made for its routine use because of radiation exposure.

Recommended screening groups

First-degree relatives of patients with AAA have increased risk, especially after age 50 years. If an initial assessment is reassuring but was performed at a relatively young age, periodic reassessment may be appropriate according to the cited European guidance.

Opportunistic assessment during transthoracic echocardiography may be considered in high-prevalence populations, particularly men aged ≥65 years and women older than 75 years. It may also be considered in patients with peripheral arterial disease.

Diagnostic Imaging

Duplex ultrasound

Duplex ultrasound is the standard technique for screening and surveillance. It can provide transverse and longitudinal aortic measurements and may demonstrate mural thrombus. Its principal advantages are availability, low cost, absence of radiation and avoidance of iodinated contrast.

Ultrasound measurements are less precise than CT or MRI measurements. Consequently, ultrasound is particularly useful for serial assessment of smaller aneurysms, whereas cross-sectional imaging is preferred when the aneurysm is large, poorly defined or being evaluated for repair.

Computed tomography

CT offers superior visualization of the abdominal aorta and its branches. Contrast-enhanced CT angiography is more accurate than ultrasound when measurements are obtained from the outer wall to the outer wall perpendicular to the aortic centerline.

CT angiography is particularly useful for determining:

• The relationship of the aneurysm to the renal, visceral and iliac arteries

• Mural thrombus and calcification

• Coexisting occlusive atherosclerosis

• Anatomic suitability for endovascular repair

• Features of inflammatory or infected aneurysms

Three-dimensional reconstructions can assist preoperative planning for endovascular aneurysm repair and may be integrated with live fluoroscopy as an procedural roadmap.

CT is recommended for preoperative planning when an AAA meets criteria for repair. It is also recommended when ultrasound does not adequately define the aneurysm. In patients with AAA of at least 4.5 cm, CT is preferred over ultrasound for more accurate measurement.

Magnetic resonance imaging

MRI and magnetic resonance angiography provide accurate assessment while avoiding ionizing radiation and, in some applications, iodine-based contrast exposure. MRI is a reasonable alternative when CT is contraindicated or when reduction of cumulative radiation is important.

For long-term follow-up, particularly in young patients and women, MRI may be favored when clinically appropriate to reduce radiation exposure. The choice should take into account patient factors, artifacts, local expertise and availability.

Aortography

Aortography may be used during EVAR and during subsequent interventions, including embolization of lumbar, inferior mesenteric or iliac branches. It is less suitable as a primary method for determining aneurysm diameter because mural thrombus can reduce the opacified lumen and cause underestimation.

Contrast aortography also carries risks, including bleeding, allergic reactions and atheroembolism.

Surveillance of an Unrepaired AAA

Surveillance intervals should be individualized according to aneurysm diameter, growth rate, sex and other clinical factors. The recommended intervals are summarized below.

The source material also summarizes a strategy of 6-month imaging for aneurysms 4.0–5.4 cm and CT or MRI confirmation and repair assessment when the diameter exceeds 5.5 cm or growth exceeds 1 cm per year. The more specific sex-based surveillance recommendations above should be applied where available.

Shorter intervals should be considered when the aneurysm expands rapidly, defined as:

• ≥10 mm per year

• ≥5 mm over 6 months

Rapid growth may prompt consideration of repair, particularly in fusiform aneurysms. Current smokers and women may require more frequent imaging because of their higher risk profile.

Assessment for Repair

For asymptomatic aneurysms, repair should generally be considered at:

• Diameter ≥5.5 cm in males

• Diameter ≥5.0 cm in females

The source material also states that repair should be considered for aneurysms ≥5.5 cm or those showing significant expansion, with referral to vascular surgery.

Earlier intervention may be reasonable for:

• Symptomatic aneurysms

• Unruptured saccular aneurysms

• Fusiform aneurysms with rapid growth of at least 0.5 cm in 6 months or 1 cm in 12 months

Symptoms suggestive of impending or actual rupture require urgent evaluation and treatment. CT is recommended for anatomic planning when repair is being considered.

Medical Management

Smoking cessation

Smoking cessation is a central component of AAA management. Continued tobacco exposure is associated with increased aneurysm expansion and rupture risk. Smoking status should therefore be assessed and cessation should be actively supported throughout surveillance.

Management of atherosclerotic disease

Patients with AAA and coexisting atherosclerotic disease benefit from statin therapy. The source material does not specify a particular statin, dose or treatment target.

Physical activity

Patients with small AAAs should exercise regularly. Moderate physical activity does not adversely affect rupture risk and may help limit aneurysm growth.

Other medical therapies

Randomized trials of metformin to limit AAA growth are described as ongoing because of findings from observational studies. The source material does not establish metformin as routine treatment and provides no recommended dose.

Acute Management of Suspected Rupture

Acute abdominal or back pain accompanied by hypotension, tenderness or other features suggestive of rupture represents a life-threatening emergency. The source material states that rupture requires emergency operation or endovascular repair.

It does not provide detailed recommendations regarding resuscitation, blood-product strategy, anesthesia, operative selection or perioperative drug therapy.

Surveillance After AAA Repair

After EVAR

Post-EVAR surveillance is intended to identify:

• Endoleak

• Aneurysm sac enlargement

• Endograft migration

• Structural graft failure

The recommended approach is:

• CT at 1 month after EVAR as baseline surveillance.

• If there is no endoleak or sac enlargement, duplex ultrasound at 12 months.

• Annual duplex ultrasound thereafter.

• Additional CT or MRI of the abdomen and pelvis every 5 years is reasonable during annual ultrasound surveillance.

• Abnormal findings on any surveillance ultrasound warrant additional CT or MRI.

• Complex EVAR may require a modified plan combining cross-sectional imaging with duplex assessment of target vessels.

Earlier surveillance protocols included imaging at 1, 6 and 12 months, but the 6-month study may be omitted when the 1-month examination shows no concerning abnormality.

After open repair

After open AAA repair, CT or MRI of the abdominopelvic aorta within 1 year is reasonable, followed by imaging every 5 years.

Open repair generally provides more durable results than endovascular treatment, although it has higher operative risk. Late complications after open repair are less frequent and are mainly related to the laparotomy.

Long-Term Follow-Up

Long-term care has two objectives: detection of post-repair complications and secondary prevention of aortic and systemic atherosclerotic disease.

For abdominal aortic intervention, CT, MRI and duplex or contrast-enhanced ultrasound may be used. Duplex and contrast-enhanced ultrasound detect the common complications of EVAR but are less suited to identifying structural graft problems. Cross-sectional imaging remains important when ultrasound is abnormal or when complex graft anatomy requires detailed assessment.

Surveillance schedules are based largely on consensus and observational evidence, and should be adapted to the patient’s anatomy, repair type, imaging findings, renal considerations, radiation exposure and local imaging expertise.

Prognosis

Prognosis depends on aneurysm size, expansion rate and the burden of coexisting coronary and cerebrovascular disease. The cited estimates indicate a 5-year rupture risk of approximately 1–2% for aneurysms smaller than 5 cm and 20–40% for aneurysms larger than 5 cm.

Rupture is always life-threatening. Aneurysmal pain may precede rupture but rupture frequently occurs without warning. Women have a higher rupture risk than men at comparable growth rates, supporting sex-specific surveillance and repair thresholds.

Small AAAs can generally be observed safely with structured imaging surveillance, provided that enlargement and symptoms are monitored and modifiable risk factors—particularly smoking—are addressed.